Search
for
Sort by
Research 31–60 of 534
- <i>In‐silico</i> Screening of ATP‐competitive Inhibitory Activities of Phytochemicals against Janus Kinase 3 and Its <i>In‐vitro</i> Evaluation
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Advances in the mechanism and new therapies of alopecia areata
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- A novel therapeutic paradigm for patients with extensive alopecia areata
- New drugs under investigation for the treatment of alopecias
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- The role of janus kinases in the treatment of autoimmune skin diseases
- Pharmacological Treatment of Alopecia
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Pharmacotherapy of alopecia areata
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias